Confluence Genetics-preview

Confluence-ag

Confluence Genetics

Private

St. Louis, MissouriHealthcare & Life Scienceshttps://confluence.ag/

Last Round

Buyout/LBO

May 23, 2025

Company Overview

Confluence Genetics is a seed innovation company that develops high-quality, nutrient-dense soybean genetics for the feed, food, and fuel markets using an AI-powered breeding platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, ML Platforms, Alternative Fuels

Business Model

B2B

Customer Profile

Revenue Share, Data as a Service

AI Layer

Application

Keywords

soybean geneticsAI crop breedinghigh protein soybeansseed innovationag-techpredictive breedinggenetics licensingspecialty soybeansanimal feed ingredientsspeed breedingvalue-added cropsplant-based proteinsCropOSUHP-LO soybeansHOLL soybeansbiofuel feedstock

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Confluence Genetics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Confluence Genetics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Buyout/LBO	May 23, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Kimberly Rameker Hurst

Chief Executive Officer

Executive Team

Aaron Robinson

Chief Operating Officer

Executive Team

Confluence Genetics Investors

Notable investors and investment history

Investor	Rounds
Verdelis Investments	Buyout/LBO
Hermann Companies	Buyout/LBO
S2G Investments	Buyout/LBO

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 21, 2026
Grew 19% QoQ, from 32 to 38 employees.
Dec 23, 2025
Grew 19% QoQ, from 31 to 37 employees.

View all signals

Confluence Genetics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Confluence Genetics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Confluence Genetics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSt. Louis, Missouri

Employee Range38

Year Founded2025

Last FundingMay 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.